Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, pharmacokinetics, and efficacy of Ipatasertib with Rucaparib in advanced breast, ovarian, and prostate cancer has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• Rucaparib (rucaparib)
• ipatasertib (ipatasertib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer, Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2023-10-30